Michigan § 333.26455 Licensing board or disciplinary committee; prohibitions; medicare certification entity; prohibitions.

Michigan Statutes

§ 333.26455 — Licensing board or disciplinary committee; prohibitions; medicare certification entity; prohibitions.

Michigan § 333.26455

Ch. 333HEALTH

Act 345 of 2014RIGHT TO TRY ACT (333.26451-333.26457)

This text of Michigan § 333.26455 (Licensing board or disciplinary committee; prohibitions; medicare certification entity; prohibitions.) is published on Counsel Stack Legal Research, covering Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mich. Comp. Laws § 333.26455 (2026).

Text

RIGHT TO TRY ACT (EXCERPT) Act 345 of 2014 333.26455 Licensing board or disciplinary committee; prohibitions; medicare certification entity; prohibitions. Sec.

5.A licensing board or disciplinary subcommittee shall not revoke, fail to renew, suspend, or take any action against a health care provider's license issued under article 15 or 17 of the public health code, 1978 PA 368, MCL 333.16101 to 333.18838 and 333.20101 to 333.22260, based solely on the health care provider's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device. An entity responsible for medicare certification shall not take action against a health care provider's medicare certification based solely on the health care provider's recommendation th

Free access — add to your briefcase to read the full text and ask questions with AI

RIGHT TO TRY ACT (EXCERPT) Act 345 of 2014 333.26455 Licensing board or disciplinary committee; prohibitions; medicare certification entity; prohibitions. Sec. 5. A licensing board or disciplinary subcommittee shall not revoke, fail to renew, suspend, or take any action against a health care provider's license issued under article 15 or 17 of the public health code, 1978 PA 368, MCL 333.16101 to 333.18838 and 333.20101 to 333.22260, based solely on the health care provider's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device. An entity responsible for medicare certification shall not take action against a health care provider's medicare certification based solely on the health care provider's recommendation that a patient have access to an investigational drug, biological product, or device.